​

Genelux Ownership | Who Owns Genelux?

OverviewRevenueFinancialsChart

Genelux Ownership Summary

Genelux is owned by 20.81% institutional investors, 11.86% insiders, and 67.33% retail investors. Marshall wace, llp is the largest institutional shareholder, holding 0% of GNLX shares.

GNLX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGenelux20.81%11.86%67.33%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Marshall wace, llp---
Tower research capital llc (trc)---
Man group---
Virtu financial---
Axxcess wealth management---
Citigroup---
Allworth financial lp---
Coppell advisory solutions---
Exchange traded concepts---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Marshall wace, llp---
Tower research capital llc (trc)---
Man group---
Virtu financial---
Axxcess wealth management---
Citigroup---
Allworth financial lp---
Coppell advisory solutions---
Exchange traded concepts---

Top Buyers

HolderShares% AssetsChange
Citigroup---8.00
Allworth financial lp---162.00
Tower research capital llc (trc)---592.00
Coppell advisory solutions---3.00K
Virtu financial---10.45K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp---156.06K
Exchange traded concepts---34.15K
Axxcess wealth management---16.67K
Man group---16.66K
Virtu financial---10.45K

Sold Out

HolderChange
Citigroup-8.00
Allworth financial lp-162.00
Tower research capital llc (trc)-592.00
Coppell advisory solutions-3.00K
Virtu financial-10.45K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20257429.82%7,269,06449.24%209.55%46130.00%11-42.11%
Dec 31, 2024571.79%4,870,849-6.84%146.44%20-4.76%1911.76%
Sep 30, 202456-22.22%5,228,245-26.41%152.64%21-48.78%17-5.56%
Jun 30, 2024729.09%7,104,51718.07%234.76%417.89%1820.00%
Mar 31, 2024668.20%6,017,4473.99%223.99%38-2.56%1550.00%

Recent Insider Transactions

DateNameRoleActivityValue
May 12, 2025Ryder Sean General CounselSell$13.07K
May 12, 2025Zindrick Thomas President and CEOSell$31.43K
May 12, 2025Yu Yong VP, Clinical Trial OperationsSell$16.29K
May 12, 2025Cappello Joseph VP, Pharmaceutical DevelopmentSell$13.83K
May 12, 2025Smalling Ralph Head of RegulatorySell$3.68K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2-5
2025 Q1--
2024 Q4-5
2024 Q3-12

GNLX Ownership FAQ

Who Owns Genelux?

Genelux shareholders are primarily institutional investors at 20.81%, followed by 11.86% insiders and 67.33% retail investors. The average institutional ownership in Genelux's industry, Biotech Stocks , is 63.84%, which Genelux falls below.

Who owns the most shares of Genelux?

Genelux’s largest shareholders are Marshall wace, llp (0 shares, 0%), Tower research capital llc (trc) (0 shares, 0%), and Man group (0 shares, 0%). Together, they hold 0% of Genelux’s total shares outstanding.

Does Blackrock own Genelux?

BlackRock is not among the top 10 institutional shareholders of Genelux.

Who is Genelux’s biggest shareholder by percentage of total assets invested?

Marshall wace, llp is Genelux’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Genelux shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools